Literature DB >> 14104611

DEMONSTRATION OF ENCEPHALOMYOCARDITIS VIRUS ANTIBODY IN HUMAN SERUMS FROM PANAMA.

J E CRAIGHEAD, P H PERALTA, A SHELOKOV.   

Abstract

Entities:  

Keywords:  ANTIBODIES; CENTRAL AMERICA; ENCEPHALITIS VIRUSES; ENCEPHALOMYOCARDITIS VIRUSES; HEMAGGLUTINATION INHIBITION TESTS; NEUTRALIZATION TESTS; SERUM ALBUMIN

Mesh：

Substances：

Year:  1963        PMID： 14104611     DOI： 10.3181/00379727-114-28714

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  4 in total

1.  Ultrastructural alterations of tissue cultures from human fetal brain infected with the E variant of EMC virus.

Authors:  M Adachi; D Amsterdam; S E Brooks; B W Volk
Journal:  Acta Neuropathol       Date:  1975-08-11       Impact factor: 17.088

2.  Light and electron microscopic studies of mouse CNS after subcutaneous administration of the E and M variants of the encephalomyocarditis virus.

Authors:  M Adachi; B W Volk; C Y Tsai; D Amsterdam; K F Wellmann
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

Review 3.  The encephalomyocarditis virus.

Authors:  Margot Carocci; Labib Bakkali-Kassimi
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

4.  A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection.

Authors:  Lindsey E Bazzone; Michael King; Christopher R MacKay; Pyae P Kyawe; Paul Meraner; Daniel Lindstrom; Joselyn Rojas-Quintero; Caroline A Owen; Jennifer P Wang; Abraham L Brass; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  mBio       Date:  2019-02-05       Impact factor: 7.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.